PF-07921585
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07921585, covering 2026-03-23 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer [Phase 1]